Adynxx Competitors and Similar CompaniesClear all
Adynxx's competitors and similar companies include Sorrento Therapeutics.
 Adynxx Adynxx is a biopharmaceutical company focused on bringing to market disease-modifying products for the treatment of pain and inflammation. |  Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| |
Founding Date | Founding Date 2007 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ San Francisco, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees N/A | Employees 31019% decrease |
Valuation ($) | Valuation ($) 87.1 k | Valuation ($) 1.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $2.2m (FY, 2018) | Revenue (est.) $62.8m (FY, 2022) |
Net income | Net income ($8.4m) (FY, 2018) | Net income ($577.8m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 23.5m | Total funding raised $ 42.6m |
For sources of this data, please see the company profile
View Company Profiles
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View company